Line Holten Reimer

Line Holten Reimer

Chief Investment Officer bei GUBRA A/S
Health Technology
Consumer Services
Finance

Profil

Line Holten Reimer currently works at Rehfeld Medical ApS, as Director from 2017 and Gubra A, as Chief Investment Officer from 2026.
Ms. Reimer also formerly worked at Alkalon A, as Director, Medbroker ApS, as Director, Reapplix A, as Director, Aros Pharma ApS, as Director, MinervaX ApS, as Director, MedicoSelskabet September 2014 ApS, as Director, Oracain ApS, as Director, TagAway Devices ApS, as Director, Dep-Xplora ApS, as Director, and SEED Capital Management I, as Investment Manager from 2003 to 2014.
Ms. Reimer received her graduate degree from the University of Vienna and graduate degree from the University of Copenhagen.

Aktive Positionen von Line Holten Reimer

UnternehmenPositionBeginn
GUBRA A/S Chief Investment Officer 01.01.2026
Direktor/Vorstandsmitglied 01.10.2017

Ehemalige bekannte Positionen von Line Holten Reimer

UnternehmenPositionEnde
Private Equity Investor 31.12.2014
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Sehen Sie sich die Erfahrung von Line Holten Reimer im Detail an

Ausbildung von Line Holten Reimer

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

41

Beziehungen ersten Grades

14

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen14

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Technology Services

  1. Börse
  2. Insiders
  3. Line Holten Reimer